Metraipolis › archive › dc_4dfcdc1951a1

Outstanding treatment success of pembrolizumab and bevacizumab combination therapy in first-line treatment of cervical sarcomatoid carcinoma: a rare case report — Europe PMC PMID:40989683

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40989683
DOI: 10.3389/fonc.2025.1586531
License (as archived): solo-consultazione
Archived: 2026-11-10T02:10:52.035Z
SHA-256 of the archived text: 550562f9285ea7cb93fb476005d7991b92cb6fc9bf6d564ea86a7a24305267e1
Stable URL of this page: https://metraipolis.com/documento/dc_4dfcdc1951a1

How to cite

Outstanding treatment success of pembrolizumab and bevacizumab combination therapy in first-line treatment of cervical sarcomatoid carcinoma: a rare case report — Europe PMC PMID:40989683 — Europe PMC (en), https://europepmc.org/article/MED/40989683 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4dfcdc1951a1 (Metraipolis archive dc_4dfcdc1951a1, sha256 550562f9285ea7cb93fb476005d7991b92cb6fc9bf6d564ea86a7a24305267e1)

BibTeX

@misc{dc4dfcdc1951a1,
  title = {Outstanding treatment success of pembrolizumab and bevacizumab combination therapy in first-line treatment of cervical sarcomatoid carcinoma: a rare case report — Europe PMC PMID:40989683},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40989683},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4dfcdc1951a1; sha256 550562f9285ea7cb93fb476005d7991b92cb6fc9bf6d564ea86a7a24305267e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40989683. Agents can read the archived copy with the MCP tool read_document.